Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Lade JM"'
Autor:
Lade JM; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Baltimore, MD, United States., Andrade MR; Department of Physiology, Johns Hopkins School of Medicine, Baltimore, MD, United States., Undem C; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Baltimore, MD, United States., Walker J; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Baltimore, MD, United States., Jiang H; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Baltimore, MD, United States., Yun X; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Baltimore, MD, United States., Shimoda LA; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Baltimore, MD, United States.
Publikováno v:
Frontiers in physiology [Front Physiol] 2023 Feb 28; Vol. 14, pp. 1108304. Date of Electronic Publication: 2023 Feb 28 (Print Publication: 2023).
Autor:
Yang Q; In Vitro ADMET Laboratories Inc., Columbia, MD (QY, APL) and Amgen Inc., San Francisco, CA (SCH, JML), United States., Humphreys SC; In Vitro ADMET Laboratories Inc., Columbia, MD (QY, APL) and Amgen Inc., San Francisco, CA (SCH, JML), United States., Lade JM; In Vitro ADMET Laboratories Inc., Columbia, MD (QY, APL) and Amgen Inc., San Francisco, CA (SCH, JML), United States., Li AP; In Vitro ADMET Laboratories Inc., Columbia, MD (QY, APL) and Amgen Inc., San Francisco, CA (SCH, JML), United States. Electronic address: lialbert@invitroadmet.com.
Publikováno v:
Biochemical pharmacology [Biochem Pharmacol] 2021 Jul; Vol. 189, pp. 114374. Date of Electronic Publication: 2020 Dec 30.
Autor:
Seneviratne HK; Division of Clinical Pharmacology, Department of Medicine, the Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Tillotson J; Division of Clinical Pharmacology, Department of Medicine, the Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Lade JM; Department of Pharmacology and Molecular Sciences, the Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Bekker LG; The Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa., Li S; Statistical Center for HIV/AIDS Research & Prevention (SCHARP), Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Pathak S; Statistical Center for HIV/AIDS Research & Prevention (SCHARP), Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Justman J; ICAP at Columbia, Mailman School of Public Health, and Division of Infectious Diseases, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York, USA., Mgodi N; University of Zimbabwe-University of California, San Francisco (UZ-UCSF) Collaborative Research Programme, Harare, Zimbabwe., Swaminathan S; Department of Medicine, Rutgers New Jersey Medical School, Newark, New Jersey, USA., Sista N; FHI 360, Durham, North Carolina, USA., Farrior J; FHI 360, Durham, North Carolina, USA., Richardson P; Department of Pathology, the Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Hendrix CW; Division of Clinical Pharmacology, Department of Medicine, the Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Bumpus NN; Division of Clinical Pharmacology, Department of Medicine, the Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Department of Pharmacology and Molecular Sciences, the Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Publikováno v:
AIDS research and human retroviruses [AIDS Res Hum Retroviruses] 2021 Mar; Vol. 37 (3), pp. 173-183. Date of Electronic Publication: 2021 Jan 13.
Autor:
Basiri B; Amgen Research, Pharmacokinetics and Drug Metabolism, 1120 Veterans Blvd., South San Francisco, CA 94080, USA. Electronic address: bbasiri@amgen.com., Xie F; Amgen Research, Pharmacokinetics and Drug Metabolism, 1120 Veterans Blvd., South San Francisco, CA 94080, USA., Wu B; Amgen Research, Hybrid Modality Engineering, One Amgen Center Drive, Thousand Oaks, CA 91320, USA., Humphreys SC; Amgen Research, Pharmacokinetics and Drug Metabolism, 1120 Veterans Blvd., South San Francisco, CA 94080, USA., Lade JM; Amgen Research, Pharmacokinetics and Drug Metabolism, 1120 Veterans Blvd., South San Francisco, CA 94080, USA., Thayer MB; Amgen Research, Pharmacokinetics and Drug Metabolism, 1120 Veterans Blvd., South San Francisco, CA 94080, USA., Yamaguchi P; Amgen Research, Cardiometabolic Disorders, One Amgen Center Drive, Thousand Oaks, CA 91320, USA., Florio M; Amgen Research, Cardiometabolic Disorders, One Amgen Center Drive, Thousand Oaks, CA 91320, USA., Rock BM; Amgen Research, Pharmacokinetics and Drug Metabolism, 1120 Veterans Blvd., South San Francisco, CA 94080, USA.
Publikováno v:
Molecular therapy. Nucleic acids [Mol Ther Nucleic Acids] 2020 Sep 04; Vol. 21, pp. 725-736. Date of Electronic Publication: 2020 Jul 10.
Autor:
Thayer MB; Amgen Research, Pharmacokinetics & Drug Metabolism, Amgen Inc., South San Francisco, CA, US., Humphreys SC; Amgen Research, Pharmacokinetics & Drug Metabolism, Amgen Inc., South San Francisco, CA, US., Chung KS; Amgen Research, Pharmacokinetics & Drug Metabolism, Amgen Inc., South San Francisco, CA, US., Lade JM; Amgen Research, Pharmacokinetics & Drug Metabolism, Amgen Inc., South San Francisco, CA, US., Cook KD; Amgen Research, Pharmacokinetics & Drug Metabolism, Amgen Inc., South San Francisco, CA, US., Rock BM; Amgen Research, Pharmacokinetics & Drug Metabolism, Amgen Inc., South San Francisco, CA, US. brooke@amgen.com.
Publikováno v:
Scientific reports [Sci Rep] 2020 Jun 26; Vol. 10 (1), pp. 10425. Date of Electronic Publication: 2020 Jun 26.
Autor:
Humphreys SC; Pharmacokinetics and Drug Metabolism Department, Amgen Research, 1120 Veterans Boulevard, South San Francisco, California 94080, United States., Thayer MB; Pharmacokinetics and Drug Metabolism Department, Amgen Research, 1120 Veterans Boulevard, South San Francisco, California 94080, United States., Campbell J; Neuroscience Department, Amgen Research, 360 Binney Street, Cambridge, Massachusetts 02141, United States., Chen WLK; Comparative Biology and Safety Sciences Department, Amgen Research, 360 Binney Street, Cambridge, Massachusetts 02141, United States., Adams D; Comparative Biology and Safety Sciences Department, Amgen Research, 360 Binney Street, Cambridge, Massachusetts 02141, United States., Lade JM; Pharmacokinetics and Drug Metabolism Department, Amgen Research, 1120 Veterans Boulevard, South San Francisco, California 94080, United States., Rock BM; Pharmacokinetics and Drug Metabolism Department, Amgen Research, 1120 Veterans Boulevard, South San Francisco, California 94080, United States.
Publikováno v:
Journal of medicinal chemistry [J Med Chem] 2020 Jun 25; Vol. 63 (12), pp. 6407-6422. Date of Electronic Publication: 2020 May 26.
Autor:
Humphreys SC; Pharmacokinetics and Drug Metabolism Department, Amgen Research, South San Francisco, California (S.C.H., M.B.T., J.M.L., B.B., R.S., B.M.R.); Hybrid Modality Engineering Department, Amgen Research, Thousand Oaks, California (B.W., K.S.); and Molecular Engineering Department, Amgen Research, Cambridge, Massachusetts (Y.H., X.H.) shumph01@amgen.com., Thayer MB; Pharmacokinetics and Drug Metabolism Department, Amgen Research, South San Francisco, California (S.C.H., M.B.T., J.M.L., B.B., R.S., B.M.R.); Hybrid Modality Engineering Department, Amgen Research, Thousand Oaks, California (B.W., K.S.); and Molecular Engineering Department, Amgen Research, Cambridge, Massachusetts (Y.H., X.H.)., Lade JM; Pharmacokinetics and Drug Metabolism Department, Amgen Research, South San Francisco, California (S.C.H., M.B.T., J.M.L., B.B., R.S., B.M.R.); Hybrid Modality Engineering Department, Amgen Research, Thousand Oaks, California (B.W., K.S.); and Molecular Engineering Department, Amgen Research, Cambridge, Massachusetts (Y.H., X.H.)., Wu B; Pharmacokinetics and Drug Metabolism Department, Amgen Research, South San Francisco, California (S.C.H., M.B.T., J.M.L., B.B., R.S., B.M.R.); Hybrid Modality Engineering Department, Amgen Research, Thousand Oaks, California (B.W., K.S.); and Molecular Engineering Department, Amgen Research, Cambridge, Massachusetts (Y.H., X.H.)., Sham K; Pharmacokinetics and Drug Metabolism Department, Amgen Research, South San Francisco, California (S.C.H., M.B.T., J.M.L., B.B., R.S., B.M.R.); Hybrid Modality Engineering Department, Amgen Research, Thousand Oaks, California (B.W., K.S.); and Molecular Engineering Department, Amgen Research, Cambridge, Massachusetts (Y.H., X.H.)., Basiri B; Pharmacokinetics and Drug Metabolism Department, Amgen Research, South San Francisco, California (S.C.H., M.B.T., J.M.L., B.B., R.S., B.M.R.); Hybrid Modality Engineering Department, Amgen Research, Thousand Oaks, California (B.W., K.S.); and Molecular Engineering Department, Amgen Research, Cambridge, Massachusetts (Y.H., X.H.)., Hao Y; Pharmacokinetics and Drug Metabolism Department, Amgen Research, South San Francisco, California (S.C.H., M.B.T., J.M.L., B.B., R.S., B.M.R.); Hybrid Modality Engineering Department, Amgen Research, Thousand Oaks, California (B.W., K.S.); and Molecular Engineering Department, Amgen Research, Cambridge, Massachusetts (Y.H., X.H.)., Huang X; Pharmacokinetics and Drug Metabolism Department, Amgen Research, South San Francisco, California (S.C.H., M.B.T., J.M.L., B.B., R.S., B.M.R.); Hybrid Modality Engineering Department, Amgen Research, Thousand Oaks, California (B.W., K.S.); and Molecular Engineering Department, Amgen Research, Cambridge, Massachusetts (Y.H., X.H.)., Smith R; Pharmacokinetics and Drug Metabolism Department, Amgen Research, South San Francisco, California (S.C.H., M.B.T., J.M.L., B.B., R.S., B.M.R.); Hybrid Modality Engineering Department, Amgen Research, Thousand Oaks, California (B.W., K.S.); and Molecular Engineering Department, Amgen Research, Cambridge, Massachusetts (Y.H., X.H.)., Rock BM; Pharmacokinetics and Drug Metabolism Department, Amgen Research, South San Francisco, California (S.C.H., M.B.T., J.M.L., B.B., R.S., B.M.R.); Hybrid Modality Engineering Department, Amgen Research, Thousand Oaks, California (B.W., K.S.); and Molecular Engineering Department, Amgen Research, Cambridge, Massachusetts (Y.H., X.H.).
Publikováno v:
Drug metabolism and disposition: the biological fate of chemicals [Drug Metab Dispos] 2019 Oct; Vol. 47 (10), pp. 1174-1182. Date of Electronic Publication: 2019 May 16.
Autor:
Barr JT; Pharmacokinetics and Drug Metabolism, Amgen Inc., South San Francisco, California., Lade JM; Pharmacokinetics and Drug Metabolism, Amgen Inc., South San Francisco, California., Tran TB; Pharmacokinetics and Drug Metabolism, Amgen Inc., South San Francisco, California., Dahal UP; Pharmacokinetics and Drug Metabolism, Amgen Inc., South San Francisco, California udahal@amgen.com.
Publikováno v:
Drug metabolism and disposition: the biological fate of chemicals [Drug Metab Dispos] 2019 Apr; Vol. 47 (4), pp. 419-423. Date of Electronic Publication: 2019 Feb 07.
Autor:
Thayer MB; Amgen Research, Pharmacokinetics and Drug Metabolism, South San Francisco, 94080, USA. mthayer@amgen.com., Lade JM; Amgen Research, Pharmacokinetics and Drug Metabolism, South San Francisco, 94080, USA., Doherty D; Amgen Research, Pharmacokinetics and Drug Metabolism, South San Francisco, 94080, USA., Xie F; Amgen Research, Pharmacokinetics and Drug Metabolism, South San Francisco, 94080, USA., Basiri B; Amgen Research, Pharmacokinetics and Drug Metabolism, South San Francisco, 94080, USA., Barnaby OS; Amgen Research, Pharmacokinetics and Drug Metabolism, Thousand Oaks, 91320, USA., Bala NS; Amgen Research, Pharmacokinetics and Drug Metabolism, South San Francisco, 94080, USA., Rock BM; Amgen Research, Pharmacokinetics and Drug Metabolism, South San Francisco, 94080, USA. brooke@amgen.com.
Publikováno v:
Scientific reports [Sci Rep] 2019 Mar 05; Vol. 9 (1), pp. 3566. Date of Electronic Publication: 2019 Mar 05.
Autor:
Narayanan B; Department of Biophysics and Biophysical Chemistry, Johns Hopkins University School of Medicine, 725 N. Wolfe Street, Hunterian 709, Baltimore, MD, USA., Lade JM; Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, 725 N. Wolfe Street, Biophysics 307, Baltimore, MD, USA., Heck CJS; Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, 725 N. Wolfe Street, Biophysics 307, Baltimore, MD, USA., Dietz KD; Department of Biophysics and Biophysical Chemistry, Johns Hopkins University School of Medicine, 725 N. Wolfe Street, Hunterian 709, Baltimore, MD, USA., Wade H; Department of Biophysics and Biophysical Chemistry, Johns Hopkins University School of Medicine, 725 N. Wolfe Street, Hunterian 709, Baltimore, MD, USA., Bumpus NN; Department of Medicine, Division of Clinical Pharmacology, Johns Hopkins University School of Medicine, 725 N. Wolfe Street, Biophysics 307, Baltimore, MD, USA.
Publikováno v:
ChemMedChem [ChemMedChem] 2018 Apr 06; Vol. 13 (7), pp. 736-747. Date of Electronic Publication: 2018 Mar 02.